Anaesthesiology and intensive care in gynaecology and obstetrics

Česká verzia

Authors: P. Štourač ¹; J. Bláha ²; M. Kosinová ¹; J. Mannová ³; P. Nosková ²; H. Harazim ¹; D. Seidlová ⁴
Authors place of work: Klinika dětské anesteziologie a resuscitace, Fakultní nemocnice Brno, Lékařská fakulta Masarykovy univerzity ¹; Klinika anesteziologie, resuscitace a intenzivní medicíny, Všeobecná fakultní nemocnice v Praze, 1. lékařská fakulta Univerzity Karlovy ²; Anestezologicko-resuscitační oddělení, Nemocnice Havlíčkův Brod ³; II. anesteziologicko-resuscitační oddělení, Fakultní nemocnice Brno ⁴
Published in the journal: Anest. intenziv. Med., 30, 2019, č. 6, s. 254-259
Category:

Summary

The article highlights and discusses several current topics that have been published in the field of anaesthesiology and intensive care in gynaecology and obstetrics in the Czech Republic and abroad last year. It summarizes the results of the international OBAAMA-INT study, which mapped the anaesthesia practice in the delivery room in the Czech Republic and Slovakia. It also presents new developments in systemic and neuroaxial obstetric analgesia, Caesarean Section anaesthesia and emergencies in pregnancy.

Keywords:

obstetric anaesthesia – obstetric analgesia – Caesarean section anaesthesia – emergency in pregnancy

Zdroje

1. Štourač P. Jaký může být potenciál mezinárodní studie OBAAMA-INT ve světle projektu OBAAMA-CZ? Anesteziologie a intenzivní medicína. 2015;26:200–201.

2. Blaha J, Stourac P, Grochova M, et al. Labor Analgesia in Czech Republic and Slovakia: a 2015 National Surveys. Int J Obstet Anesth. 2018; 35:42–51.

3. Harazim H, Stourac P, Blaha J, et al. The influence of mode of anaesthesia for caesarean delivery on neonatal Apgar scores in the Czech Republic and Slovakia: secondary analysis of the results of an international survey in 2015. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2019;163:147–154.

4. Stourac P, Kosinova M, Blaha J, et al. Changes in caesarean section anaesthesia between 2011 and 2015: Czech and Slovak national surveys. Eur J Anaesthesiol. 2019;36:801–803.

5. Štourač P, Blaha J, Noskova P, et al. Časná poporodní anestezie v České a Slovenské republice z pohledu studie OBAAMA-INT – prospektivní observační studie. Anesteziologie a intenzivní medicína. 2019;30:72–79.

6. Grochová M, Štourač P, Bláha J, et al. Peripartálna anestézia a analgézia na Slovensku a v Českej republike z ohľadu štúdie OBAAMA - INT. Anestéziológia a intenzívna medicína. 2019;8:16–22.

7. Smith LA, Burns E, Cuthbert A. Parenteral opioids for maternal pain management in labour. Cochrane Database of Systematic Reviews. 2018:321.

8. Van de Velde M. Remifentanil Patient-Controlled Intravenous Analgesia for Labor Pain Relief: Is It Really an Option to Consider? Anesthesia and Analgesia. 2017;124:1029–1031.

9. Ronel I, Weiniger CF. A broadening choice for labor analgesia: remifentanil on the a la carte menu. Int J Obstet Anesth. 2019;39:1-6.

10. Melber AA, Jelting Y, Huber M, et al. Remifentanil patient-controlled analgesia in labour: six-year audit of outcome data of the RemiPCA SAFE Network (2010-2015). Int J Obstet Anesth. 2019;39:12–21.

11. Murray H, Hodgkinson P, Hughes D. Remifentanil patient-controlled intravenous analgesia during labour: a retrospective observational study of 10 years' experience. Int J Obstet Anesth. 2019;39:29–34.

12. Logtenberg SLM, Vink ML, Godfried MB, et al. Serious adverse events attributed to remifentanil patient-controlled analgesia during labour in The Netherlands. Int J Obstet Anesth. 2019;39:22–28.

13. d'Arby Toledano R, Leffert L. Neuraxial analgesia for labor and delivery (including instrumented delivery). UpToDate. [Internet]. 2019;10 [cit. 2019 Oct 30] Dostupné z: https://www.uptodate.com/contents/neuraxial-analgesia-for-labor-and-delivery-including-instrumented-delivery?search=neuraxial%20labour%20analgesia&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1

14. de Aragio FF, de Aragao PW, Martins CA, et al. Neuraxial labor analgesia: a literature review. Rev Bras Anest. 2019;69:291–298.

15. Flett GG. Analgesia in labour: induction and maintenance. Anaesth Intensice Care Med. 2016;17:324–327.

16. Treatment of obstetric post-dural puncture headache. [Internet] 2018 [cit. 2019 Oct. 30] Dostupné z: https://www.oaa-anaes.ac.uk/assets/_managed/cms/files/Guidelines/New%20PDPH%20Guidelines.pdf

17. Resources to support safe transition from the Luer connector to NRFit™ for intrathecal and epidural procedures, and delivery of regional blocks. [Internet] 2017 [cit. 2019 Oct. 30] Dostupné z: https://improvement.nhs.uk/news-alerts/resources-support-safe-transition-luer-connector-nrfit-intrathecal-and-epidural-procedures-and-delivery-regional-blocks/

18. Guglielminotti J, Landau R, Li G. Adverse Events and Factors Associated with Potentially Avoidable Use of General Anesthesia in Cesarean Deliveries. Anesthesiology. 2019;130:912–922.

19. Gadd K, Wills K, Harle R, Terblanche N. Relationship between severe obesity and depth to the cricothyroid membrane in third-trimester non-labouring parturients: a prospective observational study. Br J Anaesth. 2018;120:1033–1039.

20. Houthoff Khemlani K, Weibel S, Kranke P, Schreiber JU. Hypnotic agents for induction of general anesthesia in cesarean section patients: A systematic review and meta-analysis of randomized controlled trials. J Clin Anesth. 2018;48:73–80.

21. Bláha J, Nosková P, Hlinecká K, et al. Surgical conditions with rocuronium versus suxamethonium in cesarean section: a randomized trial. Int J Obstet Anesth. 2019 Aug 21. pii: S0959-289X(19)30528-X.

22. Yao WY, Li SY, Yuan YJ, et al. Comparison of Supreme laryngeal mask airway versus endotracheal intubation for airway management during general anesthesia for cesarean section: a randomized controlled trial. BMC Anesthesiol. 2019;19:123.

23. Tan HS, Li SY, Yao WY, et al. Association of Mallampati scoring on airway outcomes in women undergoing general anesthesia with Supreme™ laryngeal mask airway in cesarean section. BMC Anesthesiol. 2019;19:122.

24. Markley JC, et al. Neuraxial Anesthesia During Cesarean Delivery for Placenta Previa With Suspected Morbidly Adherent Placenta: A Retrospective Analysis. Anesth Analg, 2018;127:930–938.

25. Warrick CM, Warrick MD. Rollins, Peripartum Anesthesia Considerations for Placenta Accreta. Clin Obstet Gynecol. 2018;61:808–827.

26. Beilin Y. Maternal Hemorrhage-Regional Versus General Anesthesia: Does It Really Matter? Anesth Analg. 2018;127:805–807.

27. Liu L, et al. Intrathecal dexmedetomidine can decrease the 95% effective dose of bupivacaine in spinal anesthesia for cesarean section: A prospective, double-blinded, randomized study. Medicine (Baltimore). 2019;98:e14666.

28. Kim WH, et al. Comparison between general, spinal, epidural, and combined spinal-epidural anesthesia for cesarean delivery: a network meta-analysis. Int J Obstet Anesth. 2019;37:5–15.

29. Edipoglu IS, et al. Effect of anaesthetic technique on neonatal morbidity in emergency caesarean section for foetal distress. PLoS One. 2018;13:e0207388.

30. Heesen M, et al. Ephedrine versus phenylephrine as a vasopressor for spinal anaesthesia-induced hypotension in parturients undergoing high-risk caesarean section: meta-analysis, meta-regression and trial sequential analysis. Int J Obstet Anesth. 2019;37:16–28.

31. Xu C, et al. Phenylephrine vs ephedrine in cesarean delivery under spinal anesthesia: A systematic literature review and meta-analysis. Int J Surg. 2018;60:48–59.

32. Wang X, et al. A Comparative Study of Bolus Norepinephrine, Phenylephrine, and Ephedrine for the Treatment of Maternal Hypotension in Parturients with Preeclampsia During Cesarean Delivery Under Spinal Anesthesia. Med Sci Monit. 2019;25:1093–1101.

33. Management hypertenzních onemocnění v těhotenství. [Internet] 2019 [cit. 2019 Oct. 30] Dostupné z: http://www.gynultrazvuk.cz/data/clanky/6/dokumenty/2019-06-management-hypertenznich-onemocneni-v-tehotenstvi-dp-cgps-cls-jep-revize.pdf

34. Butalia S, Audibert F, Coté AM, et al. Hypertension Canada's 2018 Guidelines for the Management of Hypertension in Pregnancy. Can J Cardiol. 2018;34:526–531.

35. Sahin AS, Ozkan S. Treatment of Obstetric Hemorrhage with Fibrinogen Concentrate. Med Sci Monit. 2019;25:1814–1821.

36. Matsunaga S, Takai Y, Seki H. Fibrinogen for the management of critical obstetric hemorrhage. Obst Gyn Res. 2019;1:13–21.

37. Snegovskikh D, Souza D, Walton Z, et al. Point-of-Care Viscoelastic Testing Improves the Outcome of Pregnancies Complicated by Severe Postpartum Hemorrhage. J Clin Anesth. 2018;44:50–56.

38. McNamara H, Kenyon C, Smith R, et al. Four years´ experience of a ROTEM -guided algorithm for treatment of coagulopathy in obstetric haemorrhage. Anaesthesia. 2019;74:961–964.

39. Osoti AO, Vogel JP, Oladapo OT, et al. Tranexamic acid for treatment of postpartum haemorrhage. Obst Gyn Reprod Med. 2019;29:146–147.

40. Peter C, Dereu D, Casini A, et al. Tranexamic acid for the management of postpartum haemorrhage: current knowledge. Rev Med. 2018;14:1861–1865.

41. Sudhoff LS, Shainker SA, Einerson BD. Tranexamic acid in the routine treatment of postpartum hemorrhage in the United States: a costeffectiveness analysis. Int J Obstet Anesth. 2018;221:275–279.

42. Franchini M, Mengoli C, Cruciany M, et al. Safety and efficacy of tranexamic acid for prevention of obstetric haemorrhage: an update systematic review and meta-analysis. Blood Transf. 2018;16:329–337.

43. Sentilhes L, Winer N, Azria E, et al. Tranexamic acid for the prevention of postpartum hemorrhage after vaginal delivery: the TRAAP trial. Int J Obstet Anesth. 2018;218:S2–S3.